Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Gemma Medcalf

- PMLiVE

NHS England sets up new £190m hep C fund

Will see patients gain access to treatments from Gilead and AbbVie

Eli Lilly HQ

Lilly and Incyte’s baricitinib aces phase III trials

Supports its potential as a therapy for rheumatoid arthritis

- PMLiVE

Patients ‘sceptical’ about biosimilars, says EULAR

Concerns for safety of drugs for arthritis and other musculoskeletal diseases

- PMLiVE

Kantar Health promotes Jade Cusick to chief client officer

Cusick will head the firm’s new global client consulting group

- PMLiVE

J&J and LDC to join forces on unmet medical needs

Collaboration will aim to find and accelerate new potential treatments

- PMLiVE

Bayer sells diabetes division to Panasonic Healthcare

€1.02bn sale includes Contour electronic meters and other medical devices

- PMLiVE

Praluent and Repatha backed for approval in US

Sanofi and Amgen remain in fierce competition in PCSK9 inhibitors

- PMLiVE

Just manufacturing pills ‘no longer good enough for patients’

Pharma must truly move beyond the pill and embrace digital health, according to industry heads

- PMLiVE

Clark Health Communications make three team additions

Announcements coincides with its Communiqué Awards nominations

- PMLiVE

Patrick Fabbio named CFO at electroCore

He joins from NPS Pharmaceuticals where he was VP finance

- PMLiVE

MRC Technology and Peptinnovate join on bone disease

Firms aim to discovery a therapy using natural peptides 

EISAI

Eisai launches thyroid cancer therapy Lenvima in UK

The UK is its first European market, with wider EU roll out expected in coming months

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links